Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.

Source:http://linkedlifedata.com/resource/pubmed/id/17693888

J. Acquir. Immune Defic. Syndr. 2007 Oct 1 46 2 222-30

Download in:

View as

General Info

PMID
17693888